Open up the world of printing anywhere in the world with these portable printers from Canon, HP, Epson, and Kodak. By Brandt Ranj Updated Jun 18, 2025 3:10 PM EDT Add Popular Science (opens in a new ...
On Friday, Claude Code creator Boris Cherny made an appearance at Meta’s @Scale conference and, surprisingly, the first question from the audience was about loops. “Are loops the next hype cycle,” the ...
Anthropic reveals that Claude now writes over 80% of its production code, with engineers shipping 8x more code per quarter than in 2024. The company’s new Anthropic Institute paper maps the path to ...
The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...
Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...
Abstract: We give a recursive construction for projective Reed-Muller codes in terms of affine Reed-Muller codes and projective Reed-Muller codes in fewer variables. From this construction, we obtain ...
Richard Socher has been a major figure in AI for some time, best known for founding the early chatbot startup You.com and, before that, his work on ImageNet. Now he’s joining the current generation of ...
It's true that 3D printers are not yet the standard of care, but the future is near. According to recent research, the dental 3D printing market in the U.S. is expected to grow at a compound annual ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results